Brief: Eiger BioPharmaceuticals Appoints Commercial Expert And Industry Veteran Kim Sablich To Its Board Of Directors
22/04/2021 13:20
April 22 (Reuters) - Eiger BioPharmaceuticals Inc EIGR.O :
* EIGER BIOPHARMACEUTICALS APPOINTS COMMERCIAL EXPERT AND
INDUSTRY
VETERAN KIM SABLICH TO ITS BOARD OF DIRECTORS
Source text for Eikon: ID:nPn6WVKvqa
Further company coverage: EIGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview